Discovery of a new blood vessel disease and its genetic cause

Researchers from Prof. Vikkula’s group at the Institute de Duve, in close collaboration with the Centre for Vascular Malformations (Prof. Laurence Boon) and the Centre for Human Genetics (Dr. Nicole Revencu) of the Cliniques Universitaires Saint-Luc, discovered a new form of hereditary vascular lesions which they called CM-AVM2.

People with this disease have capillary malformations (CM, better known as “port wine stain”), accompanied by arteriovenous malformations (AVM); the latter can have serious consequences on a person’s health.

Researchers have found that this disease is caused by mutations in a gene called EPHB4. EPHB4 is known to play an important role in the formation of blood vessels, specifically arteries and veins. The mutations identified in this disease lead to a loss of function of EPHB4, disrupting the signalling pathway within the cells that border the inner surface of blood vessels.

Researchers discovered this disease by studying families in which capillary malformations existed in several people, suggesting that they could be caused by an inherited mutation. Using Full Exome Sequencing (WES) strategy based on Next Generation Sequencing (NGS), they identified mutations in EPHB4 in 54 families (110 affected individuals).

Affected individuals have pinkish-red capillary malformations (CM), 25% of which are surrounded by a pale halo — a pathognomonic sign for this hereditary disease. In 18% of affected persons, arteriovenous malformations are also discovered, usually located in the cervicofacial region and sometimes in the central nervous system.

The discovery of the genetic basis of CM-AVM2 allows for specialised genetic counselling and, more importantly, provides the basis for developing drugs that interfere with the abnormal signalling mechanism. The results were published in the prestigious cardiovascular journal Circulation.

Similar Posts